SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-014811
Filing Date
2022-10-04
Accepted
2022-10-04 08:51:28
Documents
14
Period of Report
2022-10-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20221003x8k.htm   iXBRL 8-K 39870
2 EX-99.1 ampe-20221003xex99d1.htm EX-99.1 9291
3 GRAPHIC ampe-20221003xex99d1001.jpg GRAPHIC 10740
  Complete submission text file 0001558370-22-014811.txt   185919

Data Files

Seq Description Document Type Size
4 EX-101.SCH ampe-20221003.xsd EX-101.SCH 3282
5 EX-101.LAB ampe-20221003_lab.xml EX-101.LAB 15363
6 EX-101.PRE ampe-20221003_pre.xml EX-101.PRE 10378
8 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20221003x8k_htm.xml XML 4676
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 221289823
SIC: 2834 Pharmaceutical Preparations